Kyvor Genomics, Inc is a genome intelligence company, with a disruptive objective that “The War Against Cancer Can Be Won” using a one-of-a-kind proprietary product, an individualized cancer theragnostic* test – CANLYTx™ (Cancer + Analytics)
Funding
Self-funded (bootstrapped) company without external investments.